Pharma & Med Tech | Business Post

Uniphar first-half revenues top €1bn

Healthcare group said it had achieved its target of doubling 2018 pro forma adjusted earnings

Pre-tax profits plunge at diagnostics firm Randox

Company which was founded in a converted henhouse in Co Antrim, now employs over 2,200 staff globally

Galway-based medtech firm Vivasure secures €30m in major fundraise

New York-listed Haemonetics also has an option to buy the Irish company as part of the funding deal

Galway medtech Vivasure closes first tranche of €52m fundraise

Unnamed lead investor has option to buy the company, which is seeking FDA approval for its patch-based medical devices

Horizon Therapeutics to create 100 new jobs in Dublin

Nasdaq-listed biopharma company moved its legal headquarters to Ireland in a tax inversion in 2014

Zoan develops 3D-printed human bone grafts from locally grown coral

Company to collaborate with Swedish company Cellink on groundbreaking new project using coral grown in Connemara

Irish medtech firm Gasgon fundraises €2.25m to solve IV infusion issues

The company’s new flagship product, Airvault, is a device for removing air bubbles that negates the need for manual intervention by healthcare staff

Roscrea biopharma firm secures $100m investment ahead of plans for IPO

The Tipperary-based company aims to list on the US stock market within the coming months and believes its new drug candidates are worth at least $1 billion

South Korean company takes 30% stake in Trinity Biotech for $45m

Nasdaq-listed Trinity develops products that are sold in more than 110 countries.

Poolbeg Pharma lands deal with AI firm to pinpoint effective virus drugs

US giant OneThree Biotech will lend Open Orphan spinout its state-of-the-art technology to accelerate treatment of severe respiratory infection RSV

Jazz Pharmaceuticals wins approval for HSE reimbursement of cannabis-derived drug

The company acquired GW Pharma, the UK biopharma and producer of cannabis-derived Epidiolex, earlier this year

Belfast tech firm secures £225,000 research grant for anxiety and PTSD treatments

Neurovalens develops medical devices that deliver electrical stimulation to deep parts of the brain and nervous system

Inside story: How Chinese biopharma firm WuXi will target European market from its €1 billion Dundalk campus

In what marks a first major foreign direct investment by a Chinese multinational in this country, WuXi has built one of the largest biopharma campuses in the world where it plans to produce 50 million vaccine doses a year – the Business Post

‘I always had entrepreneurial ambitions and this was first-hand evidence of an unmet need’

Neuromod’s chief executive Dr Ross O’Neill says his company’s Lenire device, which aids tinnitus sufferers, can establish a sizeable market — particularly in the US among military veterans

PM Group reports 30% profits increase and announces 200 new jobs in Ireland

The project delivery firm said that pharmaceutical projects accounted for almost two-thirds of its overall revenue for 2020, which rose to almost €400 million

Neuromod Devices to double Irish headcount within next year

The medtech company, which specialises in neuromodulation devices indicated for the treatment of tinnitus, said it hopes to roll out its product in European countries such as France, Spain and the Netherlands

Chanelle founder invests €100k in Redesdale Group

Michael Burke has taken a stake in a firm that will seek to acquire or invest in early stage food and wellness businesses

Malin shareholders in line for windfall after €119 million cash boost

Dublin-based biotech investment fund said €45 million of the proceeds from the sale will be used to repay a European Investment Bank loan, with the remaining cash to be returned to shareholders later this year

Amryt seeks to have rare condition drug approved for payment

The Dublin company is in discussion with regulators in Britain and France to have metreleptin, a treatment for abnormal distribution of fat in the body, approved for payment reimbursement

Icon to restore staff pay as business recovers from virus

Clinical trials firm reported 10.8% drop in revenues for the three months to the end of June